Public Library of Science

SHERPA: Green

People

  1. Abramson
    Abramson
  2. Francis
    Francis
  3. Dunkel
    Dunkel
  4. Orlow
    Orlow
  5. Offit
    Offit
  6. Joseph
    Joseph
  7. Scheinberg
    Scheinberg
  8. D'Angelica
    D'Angelica
  9. Kingham
    Kingham
  10. Houghton
    Houghton

Groups

  1. GSK Faculty (149)
  2. Department of Medicine (127)
  3. Sloan Kettering Institute Faculty (103)
  4. Surgery (96)
  5. Sloan Kettering Institute Postdocs (90)
  6. Solid Tumor Oncology Division (71)
  7. Population Sciences Research Program (60)
  8. Epidemiology and Biostatistics (54)
  9. Center for Pancreatic Cancer Research (53)
  10. Center for Hematologic Malignancies (49)
Search Within
  1. "PLoS ONE"
Formats
  1. Journal Article (447)
  2. Review (3)
Groups
  1. GSK Faculty (149)
  2. Department of Medicine (127)
  3. Sloan Kettering Institute Faculty (103)
  4. Surgery (96)
  5. Sloan Kettering Institute Postdocs (90)
  6. Solid Tumor Oncology Division (71)

More Groups

People
  1. David Abramson (16)
  2. Jasmine Francis (13)
  3. Chris Sander (11)
  4. Ira Dunkel (11)
  5. Peter Allen (11)
  6. Douglas Levine (10)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (10)
  4. 2022 (12)
  5. 2021 (12)
  6. 2020 (18)

More Years

Publications
  1. PLoS ONE (450)

Results (450)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins
    Journal Article

    Zhang, W.; Rho, J. H.; Roehrl, M. W.; Roehrl, M. H.; Wang, J. Y.
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Actin clearance promotes polarized dynein accumulation at the immunological synapse
    Journal Article

    Sanchez, E.; Liu, X.; Huse, M.
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis
    Journal Article

    Kidd, M.; Drozdov, I. A.; Matar, S.; Gurunlian, N.; Ferranti, N. J.; Malczewska, A.; Bennett, P.; Bodei, L.; Modlin, I. M.
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition
    Journal Article

    Allen, A.; Qin, A. C. R.; Raj, N.; Wang, J.; Uddin, S.; Yao, Z.; Tang, L.; Meyers, P. A.; Taylor, B. S.; Berger, M. F.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • A urinary extracellular vesicle microRNA biomarker discovery pipeline; From automated extracellular vesicle enrichment by acoustic trapping to microRNA sequencing
    Journal Article

    Ku, A.; Ravi, N.; Yang, M.; Evander, M.; Laurell, T.; Lilja, H.; Ceder, Y.
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Demonstrating the impact of POLST forms on hospital care requires information not contained in state registries
    Journal Article

    Turnbull, A. E.; Ning, X.; Rao, A.; Tao, J. J.; Needham, D. M.
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies
    Journal Article

    Yamamoto, K. N.; Nakamura, A.; Liu, L. L.; Stein, S.; Tramontano, A. C.; Kartoun, U.; Shimizu, T.; Inoue, Y.; Asakuma, M.; Haeno, H.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells
    Journal Article

    Santamaria-Barria, J. A.; Zeng, S.; Greer, J. B.; Beckman, M. J.; Seifert, A. M.; Cohen, N. A.; Zhang, J. Q.; Crawley, M. H.; Green, B. L.; Loo, J. K.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma
    Journal Article

    Rustad, E. H.; Hultcrantz, M.; Yellapantula, V. D.; Akhlaghi, T.; Ho, C.; Arcila, M. E.; Roshal, M.; Patel, A.; Chen, D.; Devlin, S. M.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial - Clinical outcomes and molecular determinants of response
    Journal Article

    Murphy, C.; Muscat, A.; Ashley, D.; Mukaro, V.; West, L.; Liao, Y.; Chisanga, D.; Shi, W.; Collins, I.; Baron-Hay, S.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save